Physician profile
Patrick Manning Hranitzky
NPI 1982786083
$80,066.53
in general payments reported to CMS, 2019-2025
18 companies · $1,521 in 2025
The $1,521 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $15K · 2022: $24K · 2023: $12K · 2024: $3,580 · 2025: $1,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,724 · Food and Beverage: $6,788 · Travel and Lodging: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,723.75 |
| Food and Beverage | $6,788.05 |
| Travel and Lodging | $1,378.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $52,625.89 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $9,427.00 | 2019-2022 | |
| Boston Scientific Corporation | $6,409.97 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Cardiva Medical, INC. | $4,831.00 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Baylis Medical Company INC | $3,062.50 | 2021 | |
| Biotronik INC. | $1,102.09 | 2019-2023 | Biomonitor |
| Medtronic, INC. | $1,097.94 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Atricure, INC. | $378.46 | 2019-2024 | |
| Abbott Laboratories | $276.14 | 2021-2023 | Advisor, Jot Dx |
| Irhythm Technologies, INC. | $227.21 | 2021-2022 | |
| Medtronic Vascular, INC. | $217.22 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $146.84 | 2022-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.07 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $48.11 | 2023-2024 | Assure Wcd |
| Edwards Lifesciences Corporation | $29.29 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $23.49 | 2025 | Amvuttra |
| Celgene Corporation | $22.90 | 2024 | Camzyos |
| Cordis US Corp. | $21.41 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hranitzky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.